OBAGI NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL- hydroquinone, homosalate, octisalate, zinc oxide kit

Obagi Nu-Derm System Normal-Dry Skin Transformation Trial by

Drug Labeling and Warnings

Obagi Nu-Derm System Normal-Dry Skin Transformation Trial by is a Otc medication manufactured, distributed, or labeled by Obagi Cosmeceuticals LLC, Swiss American CDMO, LLC, G. S. Cosmeceutical USA, Inc., Bay Cities Container Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]


© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.